jili golden empire
Prospera Financial Services Inc Sells 107 Shares of The J. M. Smucker Company (NYSE:SJM)
Feels like 1979: Nottingham Forest moves into 2nd place behind rampant Liverpool in Premier League
Be more transparent with yours data billings – NCC tells network providers
Jennison Associates LLC purchased a new stake in shares of Glaukos Co. ( NYSE:GKOS – Free Report ) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 6,080 shares of the medical instruments supplier’s stock, valued at approximately $792,000. Other hedge funds have also modified their holdings of the company. Values First Advisors Inc. bought a new stake in shares of Glaukos during the 3rd quarter valued at $25,000. GAMMA Investing LLC raised its holdings in Glaukos by 68.8% during the second quarter. GAMMA Investing LLC now owns 1,192 shares of the medical instruments supplier’s stock valued at $141,000 after acquiring an additional 486 shares during the period. Fifth Third Wealth Advisors LLC purchased a new position in shares of Glaukos in the second quarter valued at about $187,000. KBC Group NV boosted its stake in shares of Glaukos by 16.2% in the third quarter. KBC Group NV now owns 1,445 shares of the medical instruments supplier’s stock worth $188,000 after acquiring an additional 201 shares during the period. Finally, Brighton Jones LLC purchased a new stake in shares of Glaukos during the second quarter worth about $208,000. 99.04% of the stock is currently owned by institutional investors. Glaukos Trading Up 2.3 % Shares of GKOS stock opened at $144.00 on Friday. The company has a market cap of $7.94 billion, a PE ratio of -47.68 and a beta of 1.02. Glaukos Co. has a 1 year low of $59.22 and a 1 year high of $146.09. The stock’s 50 day simple moving average is $132.40 and its two-hundred day simple moving average is $123.58. The company has a debt-to-equity ratio of 0.19, a current ratio of 5.54 and a quick ratio of 4.71. Analyst Upgrades and Downgrades A number of research analysts recently commented on GKOS shares. Stifel Nicolaus boosted their price target on Glaukos from $130.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. JPMorgan Chase & Co. boosted their target price on shares of Glaukos from $130.00 to $145.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. StockNews.com raised shares of Glaukos from a “sell” rating to a “hold” rating in a research note on Monday, October 21st. Piper Sandler set a $140.00 price target on shares of Glaukos in a research note on Thursday, October 17th. Finally, BTIG Research increased their price objective on shares of Glaukos from $131.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $134.55. View Our Latest Research Report on Glaukos Insider Activity at Glaukos In related news, COO Joseph E. Gilliam sold 2,275 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $138.97, for a total value of $316,156.75. Following the transaction, the chief operating officer now owns 102,169 shares of the company’s stock, valued at $14,198,425.93. This trade represents a 2.18 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website . Also, Director Gilbert H. Kliman sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $130.67, for a total transaction of $392,010.00. Following the transaction, the director now directly owns 32,336 shares in the company, valued at approximately $4,225,345.12. This trade represents a 8.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here . 6.40% of the stock is currently owned by insiders. About Glaukos ( Free Report ) Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. Read More Want to see what other hedge funds are holding GKOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Glaukos Co. ( NYSE:GKOS – Free Report ). Receive News & Ratings for Glaukos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos and related companies with MarketBeat.com's FREE daily email newsletter .VANCOUVER — Vince Dunn scored his second goal of the game 2:15 into overtime as the Seattle Kraken rallied from a three-goal, third-period deficit to defeat the Vancouver Canucks 5-4 on Saturday afternoon. Jaden Schwartz's second goal of the game tied it 4-4 with just 49 seconds left in the third period with Seattle's goaltender on the bench for an extra attacker. Matty Beniers also scored for the Kraken (16-19-2), who ended a five-game losing skid. Brock Boeser scored two goals, one on the power play, for the Canucks (17-11-7), who were playing without two star players. Conor Garland also scored his first goal in 13 games for Vancouver. Jake DeBrusk celebrated his 500th NHL game with his team-leading 16th goal and added an assist. Carson Soucy and J.T. Miller each had two assists. Canuck goaltender Thatcher Demko stopped 16 shots. Seattle goalie Philipp Grubauer made 25 saves. Vancouver defenceman Quinn Hughes and centre Elias Pettersson missed the game with undisclosed injuries. Pettersson broke out of a seven-game scoring drought with a pair of goals in Vancouver’s 4-3 win over the San Jose Sharks on Monday. He left that game in the third period. Hughes had two assists in the win over San Jose. Last year’s Norris Trophy winner as the league’s top defenceman leads the Canucks with 42 points and 34 assists. TAKEAWAYS Canucks: Vancouver has just one win in its last five games (1-2-2). The Canucks outhit the Kraken 14-3 in the first period. With Hughes out, Soucy and Tyler Myers logged over 22 minutes of ice time each. Kraken: Seattle has been outscored 27-11 during the last six games. The Kraken power play was 0 for 3 against Vancouver and has scored three times in 17 attempts the last six games. KEY MOMENT With their goaltender pulled the Kraken scored goals 1:22 apart of force the overtime. KEY STAT Boeser has five goals in his last three games. He managed just one in 13 after missing seven games with a concussion. UP NEXT Canucks: Play the Flames in Calgary on New Year’s Eve. Kraken: Return home to play Utah on Monday. This report by The Canadian Press was first published Dec. 28, 2024. Jim Morris, The Canadian Press
Previous:
Next: golden empire jili